AGN-203818

· Allergan

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for AGN-203818, covering 2008-01-07 to 2012-01-20. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Oral AGN 203818 for the Relief of Irritable Bowel Syndrome Pain [Phase 2]